New call for ”la Caixa” Doctoral INPhINIT Fellowships Programme

  Passion, commitment, curiosity... all of them essential values to awaken the talent you have inside. Now, with the aim of continuing to support the best scientific talent and fostering innovative, high quality research in Spain and Portugal, ”la Caixa” Banking Foundation is launching a new call for applications for the Doctoral INPhINIT Fellowships Programme. In this call 65 fellowships will be granted to talented ...

The 1st IBIMA-Roche Award for innovation in Oncology is awarded

  The Biomedical Research Institute of Malaga (IBIMA) and Roche Farma held this morning the ceremony of delivery of the 1st IBIMA-Roche Award for innovation in Oncology in the auditorium of the Virgen de la Victoria University Hospital. In this first edition, co-organized by both entities, the award went to the GALEN project ('From clinical trials to reality in Oncology: Usefulness of an Information System in the analysis of the ...

An article related to the prevention of anxiety, I Prize IBIMA-Divulga to the best publications of 2017

An article related to the prevention of anxiety has been selected as the best scientific publication of 2017 in the first edition of the IBIMA-Divulga Awards 2018. This act was inaugurated by the Deputy Minister of Health, María Isabel Baena, together with the Vice Chancellor for Research and Transfer of the University of Málaga (UMA), Juan Teodomiro López; and the scientific director of IBIMA, Francisco Tinahones. Also present were the ...

Researchers of the IBIMA participate in the investigation of a drug able to stop type 1 diabetes

An international team of researchers, led by Andalusians, has identified a new target and designed a new molecule capable of curbing, for the moment in mice, type 1 diabetes, a disease that appears when the individual's own immune system destroys its production cells. insulin in the pancreas. Insulin helps glucose enter cells to give them energy; without insulin there is an excess of glucose in blood that can not be removed, which produces ...

The AEMPS authorizes the Cell Therapy Unit for the manufacture of mesenchymal donor stem cells

The Spanish Agency of Medicines (AEMPS) has authorized the Cell Therapy Unit of the Regional Hospital of Malaga-Ibima, dependent on the Andalusian Initiative in Advanced Therapies, to manufacture allogenic mesenchymal stem cells (donor) for research patients participating in clinical trials, or for those who, not meeting any of the criteria for inclusion in the trial, could benefit from treatment under compassionate use. Thanks to this, cell ...

Researchers of the IBIMA and the Regional receive an international award for a study on multiple sclerosis

A research on multiple sclerosis led by researchers from the Regional Hospital of Malaga, belonging to the Group of Neuroimmunology and Multiple Sclerosis of the Biomedical Research Institute of Malaga (IBIMA), has been awarded with one of the four prizes of the second edition of the IDEA² Global program of the Massachusetts Institute of Technology (MIT) of Boston (USA). The research project 'Recombinant protein for the diagnosis and ...

FIMABIS receives the “Human Resources Excellence in Research” award from the European Commission

The European Commission has awarded the Andalusian Public Foundation for Health and Biomedicine Research in Málaga (FIMABIS) the "Human Resources Excellence in Research" award, welcoming its Action Plan 2016-2020 to implement the “Human Resources Strategy for Researchers-HRS4R” at the Institution. This accreditation recognizes the efforts of Research Institutions and Research Funding bodies to implement good practices in the recruitment ...

Informative talks about the HRS4R strategy

Two editions of an informative talk about the HRS4R strategy are called: May 19th, 2017 at 13:30 in the Hospital Materno Infantil de Málaga (Pediatric training room on the 3rd floor)May 26th, 2017 at 1:30 pm in the Virgen de la Victoria Hospital in Málaga (Hall of government (1st floor), meeting room nº 2). Dear professionals from IBIMA and FIMABIS, We kindly request your participation in the informative talk about the HRS4R strategy ...

Cellular reprogramming for Parkinsons treatment

Text in Spanish. El Parkinson es un trastorno del movimiento caracterizado por la degeneración progresiva de las neuronas dopaminérgicas de la sustancia negra cuyos síntomas más característicos son temblor de manos, brazos o piernas, rigidez y lentitud en los movimientos. En la actualidad, aunque se dispone de fármacos para paliar la sintomatología, no existen tratamientos curativos. La comunidad científica lleva décadas ...